期刊文献+

PAK4抑制剂作用模式的分子模拟研究

Molecular modeling of interaction modes of PAK4 inhibitors
原文传递
导出
摘要 目的分析PAK4(p21-活化激酶4)与抑制剂的相互作用模式,指导PAK4抑制剂的开发。方法基于PAK4的晶体结构及抑制剂的结构,利用分子对接和分子力场分析方法,探讨PAK4与抑制剂的相互作用模式。结果与结论确定了PAK4与抑制剂的作用模式,可以指导抑制剂的设计,用于开发抗肿瘤药物。 Aim To investigate the interactions between PAK4 and its inhibitors for further discovery of potent inhibitors.Methods Starting from the crystal structure of PAK4 and a small class of inhibitors,molecular docking studies and molecular field-based similarity analysis were used to analyze the interactions between PAK4 and its inhibitors.Results and conclusion The interactions between PAK4 and its inhibitor were illustrated clearly.The results obtained in this paper will be useful for designing highly active inhibitors and also in virtual screening of new compounds targeted on PAK4.
出处 《中国药物化学杂志》 CAS CSCD 2009年第5期345-348,共4页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金重大研究计划项目(90813038) 国家高技术研究发展计划项目(2007AA02Z305)
关键词 p21-活化激酶4 蛋白质-配体相互作用 分子对接 分子力场 药物设计 p21-activated kinase 4 protein-ligand interactions molecular docking molecular field drug design
  • 相关文献

参考文献8

  • 1KUMAR R,GURURAJ A E,BARNES C J. p21-Activated kinases in cancer[ J]. Nat Rev Cancer,2006,6 (6) :459 -471.
  • 2ESWARAN J, SOUNDARARAJAN M, KNAPP S. Targeting group II PAKs in cancer and metastasis [ J ]. Cancer Metastasis Rev,2009,28 ( 1/2 ) :209 - 217.
  • 3李泽,徐惠绵,李丰.p21活化激酶4在胃癌中的表达及意义[J].中华肿瘤杂志,2008,30(1):30-33. 被引量:1
  • 4LIU Y, XIAO H, TIAN Y, et al. The PAK4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice [J]. Mol Cancer Res, 2008,6 (7) :1215 - 1224.
  • 5PORCHIA L M, GUERRA M, WANG Y, et al. 2-Amino-N-{ 4-E 5-( 2-phenanthrenyl )-3-( trifluoromethyl )-1H-pyrazol-1-yl ]-phenyl} acetamide ( OSU- 03012), a celecoxib derivative, directly targets p21- activated kinase [J]. Mol Pharmacol, 2007,72 ( 5 ) : 1124 - 1131.
  • 6ESWARAN J, LEE W H, DEBRECZENI J E, et al. Crystal structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group Ⅱ PAKs[J].Structure, 2007,15 ( 2 ) : 201 -213.
  • 7BOSTROM J, GREENWOOD J R, GOTTFRIES J. Assessing the performance of OMEGA with respect to retrieving bioactive conformations [ J ]. J Mol Graph Model,2003,21 ( 5 ) :449 - 462.
  • 8CHEESERIGHT T,MACKEY M,ROSE S,et al. Molecular field technology applied to virtual screening and finding the bioactive conformation [ J ]. Expert Opin Drug Discov ,2007,2 ( 1 ) :131 - 144.

二级参考文献10

  • 1赵仲生,茹国庆,马杰.IGF-Ⅱ和HGF mRNA表达与胃癌微血管密度的关系[J].中华肿瘤杂志,2004,26(11):673-677. 被引量:27
  • 2Callow MG, Clairvoyant F, Zhu S, et al. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem, 2002, 277:550-558.
  • 3Gnesutta N, Qu J, Mindent A. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chrm, 2001, 276 : 14414-14419.
  • 4Li X, Minden A. PAK4 functions in TNF α induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem, 2005, 280:41192-41200.
  • 5Dan C, Kelly A, Bernard O, et al. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase I and cofilin. J Biol Chem, 2001, 276:32115-32121.
  • 6Barac A, Basile J, Vazquez-Prado J, et al. Direct interaction of p21-activated kinase 4 with PDZ-RhoGEF, a G protein-linked Rho guanine exchange factor. J Biol chem, 2004, 279:6182-6189.
  • 7Callow MG, Zozulya S, Gishizky ML, et al. PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci, 2005, 118 : 1861-1872.
  • 8Zhang H, Li Z, Viklund EK, et al. p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration. J Cell Biol, 2002, 158 : 1287-1297.
  • 9Wells CM, Abo A, Ridley AJ. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J Cell Sci, 2002, 115:3947- 3956.
  • 10潘阳林,毕锋,刘娜,杜静平,蒋海萍,薛妍,樊代明.Rac亚家族在胃肠道肿瘤细胞系中的表达及活性[J].中华肿瘤杂志,2003,25(5):441-444. 被引量:17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部